Happy New Year from the CPHI Middle East! As we step into 2025, we look forward to another year of groundbreaking innovations, meaningful connections, and shaping the future of the pharmaceutical industry together. Here’s to a year filled with growth, success, and collaboration. We can’t wait to see you at #CPHIME2025!
CPHI Middle East’s Post
More Relevant Posts
-
"Exciting times ahead! 🌟 Join CHROMOSEP at CPHI Milan 2024, where innovation meets excellence in the heart of Italy. Meet our experts Shailendra Gupta, Paras Shah, and Darshit Shah at Stand #6SU81 from 8th to 10th October 2024 at Fiera Milano. Let’s explore cutting-edge solutions in pharmaceutical advancements together! 💡 visit us! #CPHIMilan #CHROMOSEP #PharmaInnovation #FieraMilano #MeetTheExperts #PharmaExcellence #CPHI2024"
To view or add a comment, sign in
-
"The countdown is on ⏱️– just 4 days until #CPhI2024! 🎉 Zeiss Pharma is excited to showcase our latest innovations in pharmaceutical technology. Join us at our booth to explore cutting-edge solutions that are shaping the future of the pharma industry. Let’s connect, collaborate, and drive progress together! 🚀 See you at CPhI! #ZeissPharma #PharmaInnovation #MeetUsAtCPhI #PharmaceuticalTechnology"
To view or add a comment, sign in
-
Let's talk about your filter needs for your pharmaceutical manufacturing processes such as micronization and fluid bed processing at CPHI next week. I will be at Booth 1605, ready to work with you on the right solution!
Join SAATI at #CPHI North America, the leading event for pharmaceutical experts in the USA. From May 7 to 9, explore solutions and engage with our team at Booth 1605, Pennsylvania Convention Center, Philadelphia, PA. Discover the future of the industry, network with top professionals, and redefine possibilities with SAATI. #SAATI #SAATILife #CPHI #Filters
To view or add a comment, sign in
-
One2Treat is thrilled to be featured in today’s article from Outsourcing-Pharma. Our CEO Sébastien Coppe, discussed the transformative impact of our approach to R&D in the biopharma industry. 🌟 At One2Treat, we're not just following industry trends; we're shaping them and driving them forward. 💡 Our dedication to transforming clinical research ensures that every piece of patient data is valued, every potential treatment is thoroughly assessed, and every decision is informed by the latest advancements in the pharmaceutical sector. 🌐 Join us in revolutionizing the future of biopharma R&D. Together, we can deliver globally beneficial treatments to patients faster than ever before. 💊 https://lnkd.in/eyDG5DZJ #CPHI #DigitalInnovation #ClinicalTrials #PatientCentricDesigns #ReducedSampleSize
To view or add a comment, sign in
-
Breaking ground in the fight against amyloidosis, AstraZeneca's Amylink showcases the power of a bold brand identity to drive transformational healthcare innovation. A true example of how strategic branding fuels impactful change in rare disease care. #PEAPEXAwards #BrandStrategy #AddisonWhitney #HealthcareInnovation
🎉 We're honored to celebrate alongside AstraZeneca for their 2024 Pharmaceutical Executive APEX Award win: 🏆 Amylink | Amyloidosis Evidence Development Programme | 2023 ESC Congress launch Determined to lead the fight against amyloidosis, a rare and serious cause of heart failure, AstraZeneca launched their evidence development programme at the 2023 ESC Congress. With a bold and cohesive brand identity, this initiative reflects a deep, long-term commitment to transforming diagnosis and treatment for this challenging condition. See the brand in action: https://lnkd.in/exR54neP. #PEAPEXAwards #brandstrategy #AddisonWhitney #HealthcareInnovation
To view or add a comment, sign in
-
The article "What's in Store for 2024? Three CEOs Look Ahead and Look Back on “Close to the Edge” by Alex Philippidis provides insights from three CEOs in the pharmaceutical industry as they reflect on past achievements and anticipate future developments in the field. The CEOs offer perspectives on the evolving healthcare landscape and the challenges and opportunities that lie ahead. The CEOs discuss key industry trends that have shaped the pharmaceutical sector, emphasizing the importance of adaptability and innovation for companies to thrive in a dynamic environment. The significance of integrating advanced technologies into drug development processes was highlighted, underscoring the role of CDMOs in leveraging cutting-edge technologies to enhance efficiency and quality in ADC development. The importance of collaborative partnerships in driving innovation and accelerating drug development is discussed, showcasing the value CDMOs bring to the table through their expertise and collaborative approach. By embracing technological advancements, fostering collaborative partnerships, and anticipating future developments, KSB continues to lead ADC development with a forward-thinking approach. To learn more, visit: https://lnkd.in/gMxW4iME Article link: https://lnkd.in/ecTvK3bz #ADC #smallmolecule #peptide #CDMO #DrugDevelopment #Biotech
To view or add a comment, sign in
-
With the increasing complexity of modern clinical trials and growing restraints on internal resources, it can be a challenge to meet today’s study demands. Get the insights you need for success during AAPS PharmSci 360! Hear from LabConnect’s experts at these two sessions: 💡 Overcoming Global Analytical Challenges with Scientific Central Lab Expertise (10/22 at 11am) 💡 Overcoming Challenges: ctDNA Liquid Biopsies in Early Phase Clinical Trials (10/22 at 3:30pm) Need support now? Arrange a dedicated meeting time with our team by emailing ADSTeam@LabConnect.com. #PharmSci360 #ClinicalResearch #DrugDevelopment American Association of Pharmaceutical Scientists (AAPS) | @aapscomms Stacy Kirn-Barker John Bauer
To view or add a comment, sign in
-
Today the #BoardofDirectors of Medtech & Pharma Platform Association convened at the Novartis campus to chart the future course of action for our association. I am honored as #President to chair the #BoardofDirectors and truly inspired by the unwavering dedication and collaborative spirit demonstrated by each #member of our #Board. Together, we are committed to #fostering #synergy among the #pharmaceutical, #medtech, #diagnostic, and #tech sectors, with the aim of expanding access to vital health technologies. Your contributions are invaluable and pivotal in effecting positive change. Our association stands as a beacon of collaboration, representing #medtech, #diagnostic, #pharmaceutical, and #tech companies dedicated to advancing #combinedproducts. For those who share our passion for enhancing #cross-sectoral synergies and for improving access to health technologies, I extend an invitation to join us in our mission. Click here to learn more: https://bit.ly/3KGx1hz #Medtech #Pharma #Tech #InnovativeProducts #CombinedProducts #CombinationProducts #EuropeanUnion
Today, the Medtech & Pharma Platform Association's Board of Directors convened at the Novartis Campus to discuss the future strategy of our unique industry association, which represents medtech, diagnostic, pharmaceutical, and tech companies involved in combined products. We extend our gratitude to all Board members for their input and commitment to our mission of fostering collaboration among the pharmaceutical, medical technology, and tech sectors to advance and broaden access to combined products. Their dedication is truly making a difference! -Shayesteh Fürst-Ladani, President -Stephan A., Ypsomed AG -Daniel Delfosse, Swiss Medtech -Stephanie Horn, Roche -Manfred Maeder, Novartis -Ruth Foster, MSD -Fanny Barbotin, BD Additionally, we would like to thank the members of our Secretariat, Nathalie Schober-Ladani, Samuel Gavillet and Adrian Sutter, for their daily and unwavering support. If you are interested in joining us in our mission to improve access to combined products and enhance cross-sectoral synergies visit our website: https://bit.ly/3KGx1hz #Medtech #Pharma #Tech #InnovativeProducts #CombinedProducts #CombinationProducts #EuropeanUnion
To view or add a comment, sign in
-
Last week, Bourne attended #CPHINorthAmerica in Philadelphia to connect with thought leaders and professionals across our core areas of focus within #Pharma and #PharmaServices. Overall themes include a proactive approach, strategic focus, and adaptability of companies operating in the pharmaceutical and biotech industries. Here are our key takeaways: #CPHINA #CPHINA2024 #CPHI #BournePartners #InvestmentBanking
Bourne Briefing: CPHI North America Takeaways
To view or add a comment, sign in
-
At CPHI Milan earlier this month, we discovered that many companies across the pharmaceutical industry face the same problem: how do you position your brand to stand out in a competitive marketplace? While groundbreaking advancements in pharma and life science continue to drive the sector forward, communicating these innovations to a diverse range of audiences is tricky without the right expertise. That's where Notch comes in. We combine our understanding of the pharmaceutical industry with marketing excellence to tell your story in the best way. Learn more about how Notch can communicate your offerings with clarity, precision, and impact: https://lnkd.in/edytY_3N
To view or add a comment, sign in
6,669 followers
Head of Formulation & Technology Transfer Business Unit
1moCongrats!